Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Commission File Number 001-31914

 

 

 

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 6-K

 

 

Report of Foreign Private Issuer

Pursuant to Rule 13a-16 or 15d-16

of the Securities Exchange Act of 1934

October 26, 2023

 

 

China Life Insurance Company Limited

(Translation of registrant’s name into English)

 

 

16 Financial Street

Xicheng District

Beijing 100033, China

Tel: [phone]

(Address of principal executive offices)

 

 

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F:

Form 20-F ☒   Form 40-F ☐

 

 

 

---

Commission File Number 001-31914

 

On October 26, 2023, China Life Insurance Company Limited issued two announcements in Chinese, the English translations of which are attached as Exhibit 99.1 and Exhibit 99.2 hereto.

EXHIBIT LIST

 

Exhibit		Description
99.1		English translation of the announcement, dated October 26, 2023
99.2		English translation of the announcement, dated October 26, 2023

---

Commission File Number 001-31914

 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

						China Life Insurance Company Limited
						(Registrant)
				By:		/s/ Li Mingguang
						(Signature)
October 26, 2023				Name: Title:		Li Mingguang Principal Executive Officer and Executive Director

 

EXHIBIT 99.1

Commission File Number 001-31914

 

中國人壽保險股份有限公司

CHINA LIFE INSURANCE COMPANY LIMITED

(A joint stock limited company incorporated in the People’s Republic of China with limited liability)

(Stock code: 2628)

Announcement on the Resolutions of the Thirty-First Meeting of the Seventh Session of the

Board of Directors of China Life Insurance Company Limited

The thirty-first meeting (the “Meeting”) of the seventh session of the Board of Directors (the “Board”) of China Life Insurance Company Limited (the “Company”) was held on October 26, 2023 in Beijing. The directors were notified of the Meeting by way of a written notice dated October 12, 2023. All of the Company’s eight directors attended the Meeting in person, including Bai Tao, chairman of the Board and executive director of the Company, Li Mingguang, executive director of the Company, Wang Junhui and Zhuo Meijuan, non-executive directors of the Company, and Lam Chi Kuen, Zhai Haitao, Huang Yiping and Chen Jie, independent directors of the Company. Supervisors and members of the management of the Company also attended the Meeting as non-voting delegates. The time, venue of the Meeting and the manner in which the Meeting was convened are in accordance with the Company Law of the People’s Republic of China and the provisions under relevant laws, administrative regulations, departmental rules, Articles of Association and Rules of Procedures for the Board of Directors of the Company.

The Meeting was presided over by Mr. Bai Tao, chairman of the Board. The directors who attended the Meeting unanimously passed the following resolutions after sufficient review and discussion:

 

1.	Proposal on the 2023 Third Quarter Report of the Company

The independent directors gave their independent opinions and agreed on the changes in accounting estimates for the third quarter of 2023. Please refer to a separate announcement filed by the Company on the website of Shanghai Stock Exchange (www.sse.com.cn) on the same date of this announcement for details with respect to the changes in accounting estimates for the third quarter of 2023.

Voting result: 8 for, 0 against, with no abstention

 

2.	Proposal on Performance Target Contracts of Senior Management Members of the Company for 2023

Voting result: 8 for, 0 against, with no abstention

 

3.	Proposal on Convening the First Extraordinary General Meeting of the Company in 2023

A notice on the first extraordinary general meeting in 2023 will be announced separately.

Voting result: 8 for, 0 against, with no abstention

 

1

---

Commission File Number 001-31914

 

4.	Proposal on Amending the Administrative Measures for Investments and the Administrative Measures for the Asset Allocation of the Company

Voting result: 8 for, 0 against, with no abstention

 

5.	Proposal on Amending the Measures for the Administration of Market Risks of the Company

Voting result: 8 for, 0 against, with no abstention

 

6.	Proposal on Amending the Measures for the Administration of Insurance Risks of the Company

Voting result: 8 for, 0 against, with no abstention

 

		Board of Directors of China Life Insurance Company Limited
		October 26, 2023

 

2

EXHIBIT 99.2

Commission File Number 001-31914

 

中 國 人 壽 保 險 股 份 有 限 公 司

CHINA LIFE INSURANCE COMPANY LIMITED

(A joint stock limited company incorporated in the People’s Republic of China with limited liability)

(the “Company”)

(Stock Code: 2628)

Announcement on the Resolutions of the Fifteenth Meeting of the Seventh Session of the

Board of Supervisors of China Life Insurance Company Limited

The fifteenth meeting (the “Meeting”) of the seventh session of the Board of Supervisors of China Life Insurance Company Limited (the “Company”) (the “Board of Supervisors”) was held on October 26, 2023 in Beijing. The supervisors were notified of the Meeting by way of a written notice dated October 18, 2023. Out of the Company’s four supervisors, three supervisors attended the Meeting in person, including Cao Weiqing, the chairman of the Board of Supervisors, and Niu Kailong and Ye Yinglan, supervisors of the Company. Lai Jun, supervisor of the Company, was on leave for other business and authorized in writing, Ye Yinglan, supervisor of the Company, to act on his behalf and cast the vote for him. The time, venue of the Meeting and the manner in which the Meeting was convened are in accordance with the Company Law of the People’s Republic of China and the provisions under relevant laws, administrative regulations, departmental rules, Articles of Association (the “AOA”) of the Company and Procedural Rules for the Board of Supervisors of the Company.

The Meeting was presided over by Mr. Cao Weiqing, the chairman of the Board of Supervisors. The supervisors who attended the Meeting unanimously passed the following resolutions after sufficient review and discussion:

 

1.	Proposal on the 2023 Third Quarter Report of the Company

The Board of Supervisors reviewed and believed that: The preparation and review procedures of the 2023 Third Quarter Report of the Company are in conformity with provisions under relevant laws, regulations, the AOA and internal management regulations of the Company. The content and form of such report meet the requirements of the China Securities Regulatory Commission and the Shanghai Stock Exchange. The information contained therein reflects the operational and financial condition of the Company in the reporting period. No breach of confidentiality by the staff involved in the preparation and review of the 2023 Third Quarter Report of the Company was detected before such opinion was issued.

Voting result: 4 for, 0 against, with no abstention

 

		Board of Supervisors of China Life Insurance Company Limited
		October 26, 2023

---